Last reviewed · How we verify

NCT06766513: SLEEPDOC

Characterization of the Sleep-Wake Cycle in Traumatic Brain Injury Patients with a Disorder of Consciousness

Not yet recruiting NA Last updated 9 January 2025
What this trial tests

NA trial testing Actimetry in Trauma, Nervous System in 40 participants. Not yet recruiting.

Timeline
1 February 2025
Primary endpoint
1 February 2028
1 August 2028

Quick facts

Lead sponsorHospices Civils de Lyon
PhaseNA
StatusNot yet recruiting
Study typeINTERVENTIONAL
Allocationnon randomized
Designparallel
Maskingnone
Primary purposehealth services research
Enrollment40
Start date1 February 2025
Primary completion1 February 2028
Estimated completion1 August 2028
Sites1 location across France

Drugs / interventions tested

Conditions studied

Sponsor

Hospices Civils de Lyon — full company profile →

Who can join

18 and older, any sex, with Trauma, Nervous System or Brain Trauma. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Each year in France, 160,000 peoples suffer from a mild or severe traumatic brain injury (TBI). Sleep plays a crucial role in the process of brain plasticity, which is essential for neurological and cognitive recovery. However, the sleep-wake cycle is rarely, if ever, evaluated in patients with TBI and consciousness disorders within Post-Resuscitation Rehabilitation Units (SRPR). Caregivers develop, on a daily basis, an intuitive understanding of the patient's overall condition. This expertise deserves to be validated using objective sleep assessment tools (actigraphy). If proven accurate, it could lead to the implementation of a sleep-wake cycle evaluation protocol within SRPRs.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Actimetry

Trials testing the same drug.

Other recruiting trials for Trauma, Nervous System

Currently open trials in the same condition.

Other Hospices Civils de Lyon trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06766513.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing